Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis

This study is to evaluate the efficacy of additional concurrent chemotherapy for intermediate risk (stage II and T3N0M0) NPC patients treated with intensity-modulated radiotherapy (IMRT).440 patients with intermediate risk NPC were studied retrospectively, including 128 patients treated with IMRT al...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Zhang, Yuan, Li, Wen-Fei, Liu, Xu, Guo, Rui, Sun, Ying, Lin, Ai-Hua, Chen, Lei, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661698/
https://www.ncbi.nlm.nih.gov/pubmed/26611462
http://dx.doi.org/10.1038/srep17378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661698/
https://www.ncbi.nlm.nih.gov/pubmed/26611462
http://dx.doi.org/10.1038/srep17378

Ejemplares similares